InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2 0 Study in Acute Spinal Cord Injury orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
InVivo Therapeutics (NASDAQ:NVIV – Get Rating) and InspireMD (NYSE:NSPR – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Risk & Volatility InVivo Therapeutics has a beta of 1.26, […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Rating) in a note issued to investors on Monday. The firm set a “sell” rating on the biotechnology company’s stock. Shares of NASDAQ NVIV opened at $4.89 on Monday. The stock has a market cap of $6.80 million, a PE ratio of -0.64 and […]